FDA.reportPublic FDA data

alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]

RxCUI
1661220
RxNorm name
alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
Display name
alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
Full name
alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
103174prolastin,prolastin-c,prolastin-c liquidAlpha-1-Proteinase Inhibitor (Human)351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
91edab72-c889-470e-8315-1798b5548dcaalpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]SBD25These highlights do not include all the information needed to use PROLASTIN ® -C safely and effectively. See full prescribing information for PROLASTIN-C. PROLASTIN ® -C (Alpha 1 -Proteinase Inhibitor [Human]) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 198720220225
91edab72-c889-470e-8315-1798b5548dcaProlastin-C 1 MG InjectionPSN25These highlights do not include all the information needed to use PROLASTIN ® -C safely and effectively. See full prescribing information for PROLASTIN-C. PROLASTIN ® -C (Alpha 1 -Proteinase Inhibitor [Human]) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 198720220225
91edab72-c889-470e-8315-1798b5548dcaProlastin 1 MG InjectionSY25These highlights do not include all the information needed to use PROLASTIN ® -C safely and effectively. See full prescribing information for PROLASTIN-C. PROLASTIN ® -C (Alpha 1 -Proteinase Inhibitor [Human]) Lyophilized Powder for Solution for Intravenous Injection Initial U.S. Approval: 198720220225
2b620e6b-6a24-0957-1288-ae529c4cc3a2Prolastin-C 1 MG InjectionPSN14These highlights do not include all the information needed to use PROLASTIN-C LIQUID safely and effectively. See full prescribing information for PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha 1 -Proteinase Inhibitor [Human]) Solution for Intravenous Injection Initial U.S. Approval: 198720220705
2b620e6b-6a24-0957-1288-ae529c4cc3a2alpha 1-proteinase inhibitor, human 1 MG Injection [Prolastin]SBD14These highlights do not include all the information needed to use PROLASTIN-C LIQUID safely and effectively. See full prescribing information for PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha 1 -Proteinase Inhibitor [Human]) Solution for Intravenous Injection Initial U.S. Approval: 198720220705
2b620e6b-6a24-0957-1288-ae529c4cc3a2Prolastin 1 MG InjectionSY14These highlights do not include all the information needed to use PROLASTIN-C LIQUID safely and effectively. See full prescribing information for PROLASTIN-C LIQUID. PROLASTIN-C LIQUID (Alpha 1 -Proteinase Inhibitor [Human]) Solution for Intravenous Injection Initial U.S. Approval: 198720220705